Inventiva (IVA) Shares Issued (2022 - 2025)

Inventiva's (IVA) quarterly Shares Issued came in at $3611.0 in Q2 2025, down 18.81% year-on-year from $4447.5 in Q2 2024, and down 18.18% quarter-over-quarter from $4413.3 in Q4 2024.

Inventiva (IVA) Shares Issued (2022 - 2025) Analysis & Trends

Inventiva's Shares Issued history runs 4 years deep, the most recent figure standing at $3611.0 for Q2 2025.

  • On a quarterly basis, Shares Issued fell 18.81% year-over-year to $3611.0 in Q2 2025; TTM through Jun 2025 was $3611.0, a 18.81% decrease from a year earlier, with the FY2024 full-year figure at $4413.3, changed 0.04% from the prior year.
  • Shares Issued retreated to $3611.0 in Q2 2025 per IVA's latest filing, from $4413.3 in the prior quarter.
  • Across five years, Shares Issued topped out at $4570.7 in Q4 2022 and bottomed at $3611.0 in Q2 2025.
  • The 4-year median for Shares Issued is $4430.4 (2024), against an average of $4325.2.
  • Across the five-year window, Shares Issued rose 0.04% in 2024 and declined 18.81% in 2025, its largest moves.
  • Year by year, Shares Issued stood at $4570.7 in 2022, then fell by 3.49% to $4411.4 in 2023, then increased by 0.04% to $4413.3 in 2024, then slipped by 18.18% to $3611.0 in 2025.
  • Per Business Quant, the three latest IVA Shares Issued figures stand at $3611.0 (Q2 2025), $4413.3 (Q4 2024), and $4447.5 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 19.44 Mn
10 Inventiva 842.48 Mn 842.48 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 3,610.95
Jun 30, 2025 3,610.95
Dec 31, 2024 4,413.30
Dec 31, 2024 4,413.30
Jun 30, 2024 4,447.55
Jun 30, 2024 4,447.55
Dec 31, 2023 4,411.35
Dec 31, 2023 4,411.35
Jun 30, 2023 4,497.26
Jun 30, 2023 4,497.26
Dec 31, 2022 4,570.71
Dec 31, 2022 4,570.71